phase 2 pivotal trial of padcev in advanced urothelial cancer
Published 3 years ago • 450 plays • Length 2:21Download video MP4
Download video MP3
Similar videos
-
1:34
phase 2 trial of cv301 vaccine plus atezolizumab in advanced urothelial carcinoma
-
4:16
unite: enfortumab vedotin in advanced urothelial cancer
-
1:58
phase ii trial of nivolumab plus ipilimumab in advanced bladder cancer of variant histologies
-
1:39
phase ib trial of bintrafusp alfa for advanced urothelial cancer
-
1:29:54
examining the state of the science on new therapies in bladder cancer
-
2:58
ev-201: enfortumab vedotin for cisplatin-ineligible bladder cancer
-
1:27
dr. sonpavde on enfortumab vedotin data in bladder cancer
-
5:14
combination trials in advanced bladder cancer
-
16:47
metastatic urothelial cancer: clinical insights into trial data | shilpa gupta and petros grivas
-
2:20
ev-201: enfortumab vedotin for bladder cancer
-
1:07
dr. petrylak on the results of the ev-103 trial in bladder cancer
-
3:14
the role of enfortumab vedotin in earlier lines and stages of urothelial cancer | arjun balar
-
1:58
enfortumab vedotin for the treatment of advanced urothelial cancer
-
11:29
enfortumab vedotin plus pembrolizumab: results of the ev-302 trial with thomas powles, md
-
1:40
safety results from phase 3b strong trial of durvalumab in patients with urinary tract carcinoma
-
0:34
pembrolizumab plus enfortumab vedotin for bladder cancer
-
4:21
sacituzumab govitecan plus enfortumab vedotin for treatment of advanced urothelial cancer
-
6:57
phase ii trial of enoblituzumab for patients with intermediate/high-risk localised prostate cancer
-
3:46
perioperative management of advanced bladder cancer